Skip to main content

Table 1 Comparison of patient baseline characteristics between tumour-related death and alive or unrelated death

From: Clinical characteristics associated with primary cardiac angiosarcoma outcomes: a surveillance, epidemiology and end result analysis

 

Total

Alive or unrelated death

Tumour-related death

P value

Sex

 Female

74 (44.0%)

11 (42.3%)

63 (44.4%)

0.846

 Male

94 (56.0%)

15 (57.7%)

79 (55.6%)

 

Race

 White

113 (67.3%)

17 (65.4%)

96 (67.6%)

0.960

 Black

32 (19.0%)

5 (19.2%)

27 (19.0%)

 

 Other

23 (13.7%)

4 (15.4%)

19 (13.4%)

 

Age at diagnosis

 < 45

87 (51.8%)

18 (69.2%)

69 (48.6%)

0.053

 ≥ 45

81 (48.2%)

8 (30.8%)

73 (51.4%)

 

Marital status

 Married

93 (55.4%)

14 (53.8%)

79 (55.6%)

0.426

 Single

41 (24.4%)

8 (30.8%)

33 (23.2%)

 

 Other

27 (16.1%)

2 (7.7%)

25 (17.6%)

 

 Unknown

7 (4.2%)

2 (7.7%)

5 (3.5%)

 

Histological grade

 I

1 (0.6%)

0 (0.0%)

1 (0.7%)

0.578

 II

5 (3.0%)

2 (7.7%

3 (2.1%

 

 III

26 (15.5%)

3 (11.5%)

23 (16.2%)

 

 IV

29 (17.3%

5 (19.2%

24 (16.9%

 

 Unknown

107 (63.7%)

16 (61.5%)

91 (64.1%)

 

AJCC TNM stage

 I

1 (0.6%)

11 (42.3%)

2 (1.4%)

0.064

 II

9 (5.4%)

0 (0.0%)

8 (5.6%)

 

 III

10 (6.0%)

4 (15.4%)

6 (4.2%)

 

 IV

52 (31.0%)

0 (0.0%)

41 (28.9%)

 

 Unstaged

96 (57.1%)

11 (42.3%)

85 (59.9%)

 

Tumour size

 < 3 cm

9 (5.4%)

3 (11.5%)

6 (4.2%)

0.104

 3–5 cm

32 (19.0%)

6 (23.1%)

26 (18.3%)

 

 > 5 cm

63 (37.5%)

11 (42.3%)

52 (36.6%)

 

 Unknown

64 (38.1%)

6 (23.1%)

58 (40.8%)

 

LN metastases

 Yes

14 (8.3%)

3 (11.5%)

11 (7.7%)

0.135

 No

72 (42.9%)

15 (57.7%)

57 (40.1%)

 

 Unknown

82 (48.8%)

8 (30.8%)

74 (52.1%)

 

Distant metastases

 Yes

49 (29.2%)

11 (42.3%)

38 (26.8%)

0.088

 No

41 (24.4%)

8 (30.8%)

33 (23.2%)

 

 Unknown

78 (46.4%)

7 (26.9%)

71 (50.0%)

 

Radiation

 Yes

44 (26.2%)

11 (42.3%)

33 (23.2%)

0.004

 No/unknown

124 (73.8%)

15 (57.7%)

109 (76.8%)

 

Surgery

 Yes

80 (47.6%)

14 (53.8%)

66 (46.5%)

0.489

 No/unknown

88 (52.4%)

12 (46.2%)

76 (53.5%)

 

Summary stage

 Localized

33 (19.6%)

6 (23.1%)

27 (19.0%)

0.248

 Regional

44 (26.2%)

6 (23.1%)

38 (26.8%)

 

 Distant

87 (51.8%)

12 (46.2%)

75 (52.8%)

 

 Unstaged

4 (2.4%)

2 (7.7%)

2 (1.4%)

 

Year of diagnosis

 1973–1988

21 (12.5%)

1 (3.8%)

20 (14.1%)

0.045

 1989–2002

48 (28.6%)

4 (15.4%)

44 (31.0%)

 

 2003–2013

99 (58.9%)

21 (80.8%)

78 (54.9%)

 

Sequence number

 1st

158 (94.0%)

25 (96.2%)

133 (93.7%)

0.622

 2nd

10 (6.0%)

1 (3.8%)

9 (6.3%)